Percutaneous microwave and radiofrequency ablation for hepatocellular carcinoma: a retrospective comparative study
Ming-De Lu,Hui-Xiong Xu,Xiao-Yan Xie,Xiao-Yu Yin,Jun-Wei Chen,Ming Kuang,Zuo-Feng Xu,Guang-Jian Liu,Yan-Lin Zheng
DOI: https://doi.org/10.1007/s00535-005-1671-3
2005-01-01
Journal of Gastroenterology
Abstract:Background Percutaneous microwave ablation and radiofrequency ablation are two commonly used modalities for the treatment of hepatocellular carcinoma; however, comparisons of them have not been documented adequately. Methods Of 102 patients with biopsy-proved hepatocellular carcinoma, 49 (98 nodules) were treated percutaneously with microwave ablation and 53 (72 nodules) with radiofrequency ablation. The local tumor control, complications related to treatment, and long-term results of the two modalities were compared retrospectively. Results The complete ablation rates were 94.9% (93/98) using microwave ablation vs 93.1% (67/72) using radiofrequency ablation ( P = 0.75), and no significant differences were found either in the ablation of tumors of 3.0 cm or less ( P = 1.00) or in those of more than 3.0 cm ( P = 1.00) between the two modalities. The local recurrence rates were 11.8% (11/93) using microwave ablation vs 20.9% (14/67) using radiofrequency ablation ( P = 0.12), and there were no significant differences between the two modalities either in tumors of 3.0 cm or less ( P = 0.36) or in those of more than 3.0 cm ( P = 0.82). The rates of major complications associated with microwave ablation and radiofrequency ablation were 8.2% (4/49) vs 5.7% (3/53; P = 0.71). The disease-free survival rates in the microwave ablation group were 45.9%, 26.9%, 26.9%, and 13.4% at 1, 2, 3, and 4 years, respectively, and those in the radiofrequency ablation group were 37.2%, 20.7%, and 15.5% at 1, 2 and 3 years, respectively ( P = 0.53). The 1-, 2-, 3-, and 4-year cumulative survival rates for patients who underwent microwave ablation were 81.6%, 61.2%, 50.5%, and 36.8%, respectively, and for patients who underwent radiofrequency ablation the rates were 71.7%, 47.2%, 37.6%, and 24.2%, respectively ( P = 0.12). Conclusions Percutaneous microwave ablation and radiofrequency ablation are both effective methods in treating hepatocellular carcinomas. The local tumor control, complications related to treatment, and long-term survivals were equivalent for the two modalities.